Canada Pension Plan Investment Board
CTKB icon

Canada Pension Plan Investment Board’s Cytek Biosciences CTKB Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$180K Buy
+41,300
New +$195K ﹤0.01% 1587
2025
Q1 		– Sell
-14,300
Closed -$92.8K – 1346
2024
Q4 		$92.8K Buy
14,300
+11,900
+496% +$70.9K ﹤0.01% 1262
2024
Q3 		$13.3K Buy
+2,400
New +$13.6K ﹤0.01% 1300

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Canada Pension Plan Investment Board's CTKB Position: Q1 2026 in Review

Canada Pension Plan Investment Board opened a new position in Cytek Biosciences (CTKB) in Q1 2026: 41,300 shares worth $180K. The stake represents ﹤0.01% of the portfolio and ranks #1587 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in CTKB as recently as Q4 2024.

Canada Pension Plan Investment Board first reported a position in CTKB in Q3 2024 and has held it in 3 quarters since. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • Canada Pension Plan Investment Board held 41,300 shares of Cytek Biosciences worth $180K as of Q1 2026.
  • Cytek Biosciences was a new Canada Pension Plan Investment Board position in Q1 2026.
  • Cytek Biosciences made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1587 holding.
  • Canada Pension Plan Investment Board first reported a position in Cytek Biosciences in Q3 2024 and has held it in 3 quarters since.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.